the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …This paper quantifies the relationship between market size and innovation in the pharmaceutical industry. We estimate … the elasticity of innovation, as measured by the number of new chemical entities appearing on the market for a given …

innovation policy in the context of EU economic law (competition policy, intellectual property law, sector regulation). As such … law that moves beyond apparent conflicts and assumes innovation as the starting point. Taking this as the foundation, the … analytical grid to be used to identify ways in which economic law impacts innovation, and second an applied component that …

This paper looks at the interplay between human capital and innovation in the presence of climate and educational … moderate, short-term consumption loss. Human capital is complement to all forms of innovation and an educational policy … stimulates both energy and general purpose innovation. This result has important policy implications considering the growing …

creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage … Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated …

pharmaceuticals. We challenge this orthodox view and show, to the contrary, that the pace of innovation often is faster in a world …